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placental site nodule into a coexisting epithelioid
trophoblastic tumor and placental site
trophoblastic tumor: a case report
Bo-Jung Chen1, Chien-Jui Cheng1,2 and Wei-Yu Chen2,3*Abstract: Placental site nodules (PSNs) and epithelioid trophoblastic tumors (ETTs) respectively represent non-
neoplastic and neoplastic lesions of chorionic-type intermediate trophoblasts (ITs). Many patients with a PSN have a
history of a cesarean section (CS) or therapeutic abortion. Recent evidence shows that a PSN may progress to an
ETT. Herein, we describe a coexisting ETT and placental site trophoblastic tumor (PSTT) intimately associated with
PSNs in the post-cesarean lower uterine segment of a 41-year-old woman. The patient presented with abnormal
vaginal bleeding 1 year after a cesarean delivery for her most recent pregnancy. We speculated that the neoplasms
had transformed from PSNs, the formation of which was related to faulty expulsion of the placental tissue or
abnormal colonization of chorionic-type ITs during the CS. Neoplastic trophoblastic cells derived from PSNs
displayed differentiation plasticity toward chorionic-type ITs and implantation site ITs that were respectively
constituted of an ETT and PSTT.
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1597949195882123
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Gestational trophoblastic neoplasms are a group of fetal
trophoblastic tumors including choriocarcinomas, epi-
thelioid trophoblastic tumors (ETTs), and placental site
trophoblastic tumors (PSTTs) [1]. Recent studies dem-
onstrated distinct trophoblastic differentiation in these
tumors [1-4]. A choriocarcinoma consists of an admix-
ture of syncytiotrophoblasts, cytotrophoblasts, and inter-
mediate trophoblasts (ITs), whereas an ETT and PSTT
respectively show differentiation of chorionic-type ITs
and implantation-site ITs. Mixed gestational tropho-
blastic neoplasms of combinations of choriocarcinomas,
ETTs, and/or PSTTs were also described [3,5-7]. The most
common combination is a choriocarcinoma admixed with* Correspondence: 1047@tmu.edu.tw
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reproduction in any medium, provided the oran ETT and/or PSTT. To our knowledge, only one case of
a mixed ETT and PSTT was reported in the literature [3].
Although cellular differentiation of gestational tropho-
blastic neoplasms has clearly been elucidated, their patho-
genesis remains poorly understood. In contrast to
choriocarcinomas that commonly occur subsequent to a
molar pregnancy, only a minority of cases with an ETT or
PSTT had an antecedent molar pregnancy [1,4]. Little is
known about the morphologic transition from a precursor
lesion to a gestational trophoblastic neoplasm. Herein, we
report a case of a coexisting ETT and PSTT centered in
the post-cesarean lower uterine segment. Placental site
nodules (PSNs) were intimately associated with the neo-
plasm. We speculated that the formation of these PSNs
was related to a cesarean section (CS), and the PSNs sub-
sequently progressed to the coexisting ETT and PSTT.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Clinical summary
A 41-year-old woman presented with abnormal vaginal
bleeding for 2 months. She had a history of two cesarean
deliveries and one spontaneous abortion. She had under-
gone excision of a uterine adenomyosis 3 years previous.
Her latest pregnancy resulted in the delivery of a full-
term baby 1 year previous. The physical examination
was otherwise normal. Pelvic ultrasonography showed
focal thickening of the endometrium. She received endo-
metrial curettage with a clinical diagnosis of endometrial
hyperplasia. A serum β-human chorionic gonadotropin
(β-hCG) measurement was performed 1 week later be-
cause an IT tumor was suspected after pathologic examin-
ation of the endometrial curettage specimen. The β-hCG
level was not elevated (1 mIU/ml; reference range: 0 ~ 5
mIU/ml). The abdominal and pelvic computed tomo-
graphic scans exhibited an enlarged uterus with an irregu-
lar contour and heterogeneous contrast enhancement
without para-aortic or pelvic lymphadenopathy. No meta-
static lesion was detected on a chest x-ray. She underwent
a total abdominal hysterectomy. Neither postoperative
chemotherapy nor radiotherapy was given. She was alive
with no evidence of local recurrence or distant metastasis
30 months after the hysterectomy.hPL CD146
G H
Pathologic findings
On macroscopic examination, the uterus measured 9.0 ×
8.3 × 4.2 cm and was slightly enlarged. The serosa
showed focal fibrosis. The previous CS site of the lower
uterine segment revealed a markedly thinned myome-
trium. There was an irregular, plaque-like, soft, brownish
tumor centered at the CS site (Figure 1A, B). The tumor
was 3.0 × 2.0 cm in dimensions and 0.9 cm in thickness.A B
Figure 1 Macroscopic features of a coexisting epithelioid
trophoblastic tumor (ETT) and placental site trophoblastic
tumor (PSTT) at the cesarean section site. (A) An irregular,
plaque-like, soft, brown tumor centered at the previous cesarean
section site (arrow). Adenomyosis with thickened myometrium was
noted in the myometrium (arrowhead). (B) Tumor invasion into the
myometrium of the lower uterine segment (arrow). The uterine
corpus and cervix are on the right and left, respectively.It had invaded the myometrium but was still confined to
the uterus.
Histologically, the tumor consisted of variably sized
nodules with central fibrinoid necrosis in the endomet-
rium and myometrium of the lower uterine segment
(Figure 2A). Suture material and suture tracts due to theFigure 2 Histologic and immunohistochemical features of a
coexisting epithelioid trophoblastic tumor (ETT) and placental
site trophoblastic tumor (PSTT) transformed from placental site
nodules (PSNs) at the cesarean section site. (A) A scanning view
of the mixed ETT and PSTT shows variably sized nodules with
central fibrinoid necrosis (arrow). In the deep myometrium, a suture
tract, which was closely associated with the mixed ETT and PSTT,
was noted (arrowhead). The tract was surrounded by PSNs. Note the
suture material at the outermost surface of the lower uterine
segment (asterisk). (B) Transformation of PSNs into the mixed ETT
and PSTT. PSNs (arrowhead) located around the suture tract showed
continuity with the mixed ETT and PSTT on the right. (x200) (Inset,
p63 expression in PSN). (C) A tumor nodule composed of an ETT in
the center (arrow) and a PSTT in the periphery (arrowhead) (x100).
(D) p63 expression highlighting the ETT of the tumor nodule in
Figure 2C (x100). (E) and (F) PSTT of the tumor nodule in Figure 2C
demonstrated by immunoreactivity to hPL and CD146 (x100).
(G) ETT composed of mononucleate epithelioid cells arranged in
cohesive sheets. The tumor cells had distinct cell borders, clear
cytoplasm, and uniform nuclei (x400). (H) PSTT dissecting and
separating smooth muscle bundles of the myometrium (x400). (A, B
C, G, and H, hematoxylin-eosin).
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revealed an infiltrating border in the myometrium.
The center of the nodules was composed of mononu-
cleate epithelioid cells arranged in cohesive sheets
(Figure 2C, G). The background contained hyaline
extracellular matrix. The tumor cells had distinct cell
borders, clear cytoplasm, and relatively uniform round
nuclei with fine chromatin. Enlarged hyperchromatic
nuclei were occasionally found. Mitotic figures were
infrequent. Epithelioid clear cells revealed diffuse and
strongly positive immunoreactivity to pan-cytokeratin
(clone AE1/AE3, 1: 400; Dako, Carpentaria, CA, USA),
p63 (clone 4A4, 1: 100; Santa Cruz Biotechnology, Santa
Cruz, CA, USA), and HLA-G (a gift of Dr. Ie-Ming Shih)
(Figure 2D). Human placental lactogen (hPL) (1: 250;
Pierce Biotechnology, Rockford, IL, USA) and CD146 (1:
50; Pierce Biotechnology) were negative (Figure 2E, F). No
cell immunoreactive with hCG (1: 300; Dako) was found.
Ki-67 (clone MIB-1, 1:50; Dako) labeled 12% of tumor
cells. The morphologic and immunohistochemical fea-
tures of the epithelioid cells were characteristic of an ETT.
In the periphery of the nodules, larger pleomorphic cells,
which histologically and immunohistochemically differed
from tumor cells of the ETT, were seen (Figure 2C, H).
They were polygonal with abundant eosinophilic cytoplasm
and relatively obvious nuclear atypia. They had invaded the
myometrium in cell cords, dissecting and separating the
smooth muscle bundles. They were immunoreactive for
CD146 and hPL but negative for p63 (Figure 2D-F). Ki-67
labeled about 10% of the tumor cells. These histologic and
immunohistochemical findings were consistent with
features of a PSTT. At the interface of the ETT and
PSTT components, both type of tumor cells merged
imperceptibly.
In addition, several microscopic hypocellular nodular le-
sions, closely associated with the mixed ETT and PSTT,
were found in the endometrium of the lower uterine seg-
ment, the surface of the endocervix, and the fibrous scar
of the CS (Figure 2B). They had circumscribed margins
and were round or plaque-like in shape. They were com-
posed of mononucleate ovoid cells arranged in single cells
and small sheets in a hyaline background. These cells had
uniform nuclei with fine chromatin. The immunohisto-
chemical findings were the same to those of the ETT.
Compared to the ETT, the nodular lesions were smaller in
size and paucicellular. No necrosis was found. The Ki-67
proliferation index was <5%. Based on the histologic and
immunohistochemical features, the smaller nodular le-
sions represented PSNs. In summary, the tumor repre-
sented a rare example of a coexisting ETT and PSTT that
had likely transformed from PSNs. Microscopic findings
of the endometrial curettage specimen were similar to
those of the hysterectomy specimen, except that no PSNs
were present in the former.Discussion
ETTs and PSTTs are rare gestational trophoblastic neo-
plasms, with respective differentiation toward chorionic-
type ITs and implantation-site ITs [1]. The non-neoplastic
counterpart of an ETT is a PSN, whereas that of a PSTT
is an exaggerated placental-site reaction (EPSR). The
pathogenesis of ETTs and PSTTs remains obscure. A re-
cent study demonstrated a lack of a biologic link between
an EPSR and PSTTs [8]. However, atypical PSNs with
morphologic features intermediate between typical PSNs
and ETTs were described [4,9]. Transformation of a PSN
through an atypical PSN to a malignant ETT was also
reported [10]. In a clinicopathologic study of 14 cases of
ETTs, two cases were intimately associated with PSNs [3].
Those findings suggest that PSNs have the potential to de-
velop into ETTs. The transition from a PSN to a
coexisting ETT and PSTT in the current case further sup-
ports the concept. Moreover, a similar distribution of
ETTs and PSNs in the uterus also implies a link between
them. Approximately half of ETT cases and 40% of PSN
cases are located in the lower uterine segment and/or
upper endocervix [3,4,9,11,12]. A recent study showed a
lack of a Y-chromosome complement in >80% of cases of
ETTs [13]. Analysis of the Y allele in PSNs may be helpful
to further clarify the relationship between ETTs and PSNs.
Normal placental-site tissue is expelled from the
uterus within several weeks postpartum [11]. Factors
contributing to the retention of ITs that lead to PSN for-
mation remain unclear. Much evidence supports surgical
interventions, including CSs and therapeutic abortions,
being related to PSN formation. Many patients with
PSNs have a history of a therapeutic abortion and/or CS
[4,11]. Fistulous tracts of the lower uterine segment,
coated by ITs resembling PSNs, were described in patients
who had received a CS [14-17]. The endometrium dam-
aged by a CS or therapeutic abortion might not undergo
cyclic shedding during subsequent menstrual cycles. Per-
turbation of endometrial shedding may contribute to PSN
formation [12]. The present case showed distribution of
PSNs at the CS site, which supports the relationship be-
tween PSN formation and surgical interventions.
Interestingly, our case showed mixed features of an ETT
and PSTT. The frequency of ETTs combined with other
gestational trophoblastic neoplasms is not low. In fact, the
histologic, ultrastructural, and immunohistochemical fea-
tures of ETTs were first described in lungs of patients with
a choriocarcinoma following intensive chemotherapy
[18,19]. The largest clinicopathologic study of ETTs, that
included 14 patients, showed three cases combined with a
choriocarcinoma and/or a PSTT [3]. Only one case of a
mixed ETT and PSTT without a choriocarcinoma compo-
nent was found in the literature [3]. The 15-year-old pa-
tient had a history of a preceding complete mole 1 year
before the diagnosis of the mixed ETT and PSTT.
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The serum β-HCG level was not available. The tumor was
limited to the uterus. She underwent a hysterectomy with-
out postoperative chemotherapy and had no evidence of
tumor recurrence or metastasis 84 months later. The two
cases of a mixed ETT and PSTT, including ours, had clin-
ical presentations similar to those of a pure PSTT or ETT
[3,7,20,21]. With a pure PSTT or ETT, abnormal vaginal
bleeding is the most common presenting symptom, and
serum β-HCG levels are elevated in approximately 80% of
patients. Because only two cases of a mixed ETT and
PSTT were reported, it is difficult to establish the prog-
nostic factors of the tumor. These two cases, both of
which had a tumor limited to the uterus, like most pa-
tients with a stage I pure ETT or PSTT, had a favorable
prognosis after a hysterectomy. The clinical behavior of a
mixed ETT and PSTT seems similar to that of a pure ETT
or PSTT, but more cases are required to elucidate its
prognosis. Long-term follow-up is essential for patients
with a mixed ETT and PSTT, because patients with a stage
I pure ETT or PSTT occasionally have local recurrence or
distant metastasis during the follow-up period [3,7,20,21].
As the β-HCG level was not elevated in 20% of patients
with a PSTT or ETT, glypican 3 was recently suggested to
be a potential serum tumor marker of gestational tropho-
blastic neoplasms [22]. The role of glypican 3 as a tumor
marker needs further clinical evaluation.
The hybrid features of the present tumor were consist-
ent with the proposed model of pathogenesis of gesta-
tional trophoblastic neoplasms [2,4]. In this model,
transformed trophoblastic stem cells retain differentiation
plasticity. Stem cells are able to differentiate toward
cytotrophoblast, syncytiotrophoblast, chorionic-type ITs
and implantation-site ITs. This model also explains the
sensitivity of trophoblastic neoplasms to chemotherapy.
Choriocarcinomas, the most primitive trophoblastic tu-
mors, are sensitive to chemotherapy. Conversely, ETTs
and PSTTs are not responsive to chemotherapy due to
their more-differentiated natures. Because of the differen-
tiation plasticity of neoplastic trophoblasts, it is clinically
critical for pathologists to thoroughly examine pathologic
specimens, particularly small curettage samples, to iden-
tify components of trophoblastic neoplasms: ETTs,
PSTTs, choriocarcinomas, or their combinations. Thera-
peutic approaches to gestational trophoblastic tumors ra-
ther depend on the differentiation of neoplastic
trophoblasts. An immunohistochemical panel including
cytokeratin 18, HLA-G, HSD3B1, β-HCG, β-catenin, hPL,
CD146, p63, and Ki-67 can be of great help in establishing
a correct diagnosis [2].
Conclusion
This report supports PSNs possibly being precursor le-
sions of trophoblastic neoplasms. The present caseshowed that PSNs had transformed into rare gestational
trophoblastic neoplasms which were composed of ETTs
and PSTTs. Although PSNs are non-neoplastic lesions of
chorionic-type ITs, some trophoblasts of PSNs still re-
tain differentiation plasticity and can differentiate into
other trophoblasts such as implantation-site ITs in the
present tumor. The intimate association between PSNs
and the CS scar indicates that surgical interventions may
lead to retention of ITs in the uterus. The present case
represents an extremely rare complication of a CS.
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